Piedmont Heart Grand Rounds:
Hypertrophic Cardiomyopathy (HCM) is a genetic cardiovascular disease. Kenneth Taylor, M.D., director of the HCM Center at Piedmont Heart, provides an overview including diagnosis, the newest treatment options, the latest protocols, and when to refer to Piedmont’s team of HCM specialists. Learn more at piedmont.org/HCM.
Earn CME
The planners for this activity report no relevant financial relationships. Dr. Taylor, presenter in this activity, reports he is a speaker for Bristol Myers Squibb. All relevant financial relationships have been mitigated by Piedmont Healthcare.
In support of improving patient care, Piedmont Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Piedmont Healthcare designates this enduring activity for a maximum of 0.75 AMA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
To receive CME credit, please complete the competency questions and evaluation.
Earn CME Credit
References
1. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P,Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2020;76:e159–240.